Caris Life Sciences: Piper Sandler raises target price to $25 from $22
CAI•Piper Sandler raised its target price for Caris Life Sciences to $25 from $22.
Related News
Vistra target price raised to $178 from $176
VST•
China's trade surplus soars past $1 trillion as AI boom powers exports
FXI•
Australian business forward orders slump in October, NAB survey shows
SPY•
Exxon signs preliminary agreement with Venezuela to evaluate oil opportunities
XOM•
Karat Packaging CFO Jian Guo reports acquisition of $6,003.72 in common shares
KRT•